Hos patienter med tidligere tilfælde af leverdysfunktion, herunder kronisk aktiv hepatitis, er der en øget forekomst af unormal leverfunktion under antiretroviral kombinationsbehandling, og disse patienter bør monitoreres i henhold til standardprocedurer.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.